Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a.

by Noha Sharaf Eldin, Soheir Ismail, Hala Mansour, Claire Rekacewicz, Moustafa El-Houssinie, Sherif El-Kafrawy, Saeed El Aidi, Mohamed Abdel-Hamid, Gamal Esmat, Stanislas Pol, Arnaud Fontanet, Mostafa K Mohamed
Published 2008-01-01

A novel method to identify routes of hepatitis C virus transmission.

by Cyrille Féray, Julie Bouscaillou, Bruno Falissard, Mostafa K Mohamed, Naglaa Arafa, Iman Bakr, Mostafa El-Hoseiny, Mai El Daly, Sherif El-Kafrawy, Sabine Plancoulaine, Mohamed Abdel-Hamid, Valérie Thiers, Arnaud Fontanet
Published 2014-01-01

Injection drug use is a risk factor for HCV infection in urban Egypt.

by Adela Paez Jimenez, Mostafa K Mohamed, Noha Sharaf Eldin, Hasnaa Abou Seif, Said El Aidi, Yehia Sultan, Nasr Elsaid, Claire Rekacewicz, Mostafa El-Hoseiny, May El-Daly, Mohamed Abdel-Hamid, Arnaud Fontanet
Published 2009-01-01

Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study

by Dr. Romulus Breban, PhD, Naglaa Arafa, PhD, Sandrine Leroy, PhD, Aya Mostafa, PhD, Iman Bakr, PhD, Laura Tondeur, MSc, Prof. Mohamed Abdel-Hamid, PhD, Prof. Wahid Doss, PhD, Prof. Gamal Esmat, MD, Prof. Mostafa K Mohamed, PhD, Prof. Arnaud Fontanet, PhD
Published 2014-09-01